Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease

Neuroreport. 2000 Nov 9;11(16):3599-601. doi: 10.1097/00001756-200011090-00039.

Abstract

The APOE4 allele is widely accepted as a major risk factor for late-onset Alzheimer's disease (AD). Recently, it has been reported that polymorphisms in the APOE promoter and in the alpha2-macroglobulin gene (A2M) are associated with AD. We have analyzed the distribution of APOE alleles, -219T/G APOE promoter polymorphism, and A2M/A2Mdel polymorphism in a large case-control study. Our results showed that APOE genotype was the only informative marker of AD risk contrary to -219T/G and A2M/A2Mdel polymorphism. In AD patients however, a strong linkage disequilibrium was observed between the T allele of -219T/G polymorphism and APOE4 allele. This result indicates that -219T/G APOE promoter polymorphism is a risk factor for AD by increasing the APOE4-associated risk.

MeSH terms

  • Aged
  • Alleles
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • France
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Linkage Disequilibrium
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic*
  • Reference Values
  • Risk Factors
  • White People
  • alpha-Macroglobulins / genetics*

Substances

  • Apolipoprotein E4
  • Apolipoproteins E
  • alpha-Macroglobulins